Learning Objectives:

  1. Identify key coagulation cascade targets for anticoagulant therapy

  2. Review trials examining DOAC efficacy for VTE treatment

  3. Learn about recent data regarding the use of DOACs for cancer associated VTE

Session date: 
03/19/2018 - 12:00pm to 1:00pm CDT
University of Chicago Medicine
5841 South Maryland Avenue
MC2115 HemOnc Conference Room E-215
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Kenneth Cohen MD